- Home
- ENLV vs NEPH Comparison
ENLV vs NEPH Comparison
Compare ENLV & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- NEPH
- Stock Information
- Founded
- ENLV 2005
- NEPH 1997
- Country
- ENLV Israel
- NEPH United States
- Employees
- ENLV N/A
- NEPH N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- NEPH Medical/Dental Instruments
- Sector
- ENLV Health Care
- NEPH Health Care
- Exchange
- ENLV Nasdaq
- NEPH Nasdaq
- Market Cap
- ENLV 20.7M
- NEPH 16.8M
- IPO Year
- ENLV 1995
- NEPH 2004
- Fundamental
- Price
- ENLV $0.98
- NEPH $2.01
- Analyst Decision
- ENLV Strong Buy
- NEPH Buy
- Analyst Count
- ENLV 2
- NEPH 1
- Target Price
- ENLV $10.00
- NEPH $5.00
- AVG Volume (30 Days)
- ENLV 63.0K
- NEPH 11.3K
- Earning Date
- ENLV 06-13-2025
- NEPH 05-08-2025
- Dividend Yield
- ENLV N/A
- NEPH N/A
- EPS Growth
- ENLV N/A
- NEPH N/A
- EPS
- ENLV N/A
- NEPH 0.01
- Revenue
- ENLV N/A
- NEPH $14,162,000.00
- Revenue This Year
- ENLV N/A
- NEPH $9.23
- Revenue Next Year
- ENLV N/A
- NEPH $12.99
- P/E Ratio
- ENLV N/A
- NEPH $279.15
- Revenue Growth
- ENLV N/A
- NEPH N/A
- 52 Week Low
- ENLV $0.81
- NEPH $1.36
- 52 Week High
- ENLV $1.84
- NEPH $2.55
- Technical
- Relative Strength Index (RSI)
- ENLV 53.70
- NEPH 59.37
- Support Level
- ENLV $0.87
- NEPH $1.86
- Resistance Level
- ENLV $0.91
- NEPH $2.05
- Average True Range (ATR)
- ENLV 0.06
- NEPH 0.10
- MACD
- ENLV 0.01
- NEPH -0.01
- Stochastic Oscillator
- ENLV 90.31
- NEPH 87.02
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.